Hey 514!, CBYL seems to have multiple personalities and ‘Turd’ arguably one of them with the trouble they have had getting traction. One theory about the increase in volume I’ve been reading is rumor’s that stem from the M&A chatter that stemmed from CBYL’s April 15 corporate action 8k. Can you or someone in your circle of friends locate any dd that puts some meat on the rumor (I suck ;( – like an obvious suitor that has ‘shown their hand’ so to speak, in past dealings. Volume usually speaks volumes so wondering what’s behind it (and of course would like a good trade entry ;). On the other hand CBYL probably in her seductress personality shagged these horny losers ; < )..
Goldman Sachs Group Inc. Has $377,000 Stake in Carbylan Therapeutics Inc (CBYL)
Goldman Sachs Group Inc. boosted its stake in Carbylan Therapeutics Inc (NASDAQ:CBYL) by 544.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 585,460 shares of the specialty pharmaceutical company’s stock after buying an additional 494,641 shares during the period. Goldman Sachs […]
Carbylan Therapeutics Inc (CBYL) Downgraded by Zacks Investment Research to “Hold”
Zacks Investment Research cut shares of Carbylan Therapeutics Inc (NASDAQ:CBYL) from a buy rating to a hold rating in a research report sent to investors on Wednesday. According to Zacks, “Carbylan Therapeutics, Inc. is a specialty pharmaceutical company which focused on the development and commercialization of combination therapies that address unmet medical needs. The Company’s […]
